1. Home
  2. THAR vs NVFY Comparison

THAR vs NVFY Comparison

Compare THAR & NVFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • NVFY
  • Stock Information
  • Founded
  • THAR 2017
  • NVFY 2003
  • Country
  • THAR United States
  • NVFY United States
  • Employees
  • THAR N/A
  • NVFY N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • NVFY Home Furnishings
  • Sector
  • THAR Health Care
  • NVFY Consumer Discretionary
  • Exchange
  • THAR Nasdaq
  • NVFY Nasdaq
  • Market Cap
  • THAR 2.8M
  • NVFY 3.2M
  • IPO Year
  • THAR 2022
  • NVFY N/A
  • Fundamental
  • Price
  • THAR $2.13
  • NVFY $0.45
  • Analyst Decision
  • THAR
  • NVFY
  • Analyst Count
  • THAR 0
  • NVFY 0
  • Target Price
  • THAR N/A
  • NVFY N/A
  • AVG Volume (30 Days)
  • THAR 232.7K
  • NVFY 78.3K
  • Earning Date
  • THAR 11-07-2024
  • NVFY 11-14-2024
  • Dividend Yield
  • THAR N/A
  • NVFY N/A
  • EPS Growth
  • THAR N/A
  • NVFY N/A
  • EPS
  • THAR N/A
  • NVFY N/A
  • Revenue
  • THAR N/A
  • NVFY $9,955,064.00
  • Revenue This Year
  • THAR N/A
  • NVFY N/A
  • Revenue Next Year
  • THAR N/A
  • NVFY N/A
  • P/E Ratio
  • THAR N/A
  • NVFY N/A
  • Revenue Growth
  • THAR N/A
  • NVFY N/A
  • 52 Week Low
  • THAR $1.84
  • NVFY $0.39
  • 52 Week High
  • THAR $8.55
  • NVFY $6.38
  • Technical
  • Relative Strength Index (RSI)
  • THAR 46.63
  • NVFY 29.21
  • Support Level
  • THAR $2.09
  • NVFY $0.40
  • Resistance Level
  • THAR $2.27
  • NVFY $0.50
  • Average True Range (ATR)
  • THAR 0.17
  • NVFY 0.06
  • MACD
  • THAR -0.00
  • NVFY 0.02
  • Stochastic Oscillator
  • THAR 34.04
  • NVFY 28.06

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About NVFY Nova Lifestyle Inc.

Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.

Share on Social Networks: